social anxiety disorder

Fluvoxamine Antidepressant Drug Being Tested for COVID-19 Treatment

Medicine & Technology Mar 08, 2021

The 40-year-old antidepressant drug, Fluvoxamine is currently being tested as a potential treatment for COVID-19. It has been authorized by the FDA to be considered for those at high risk of suffering severe symptoms of COVID-19.

social anxiety disorder

Fluvoxamine Antidepressant Drug Being Tested for COVID-19 Treatment

Most Popular

How Technology Is Changing the Real Estate Industry?

How a Plant-Based Diet Can Protect Against Breast Cancer: Insights from Nutrition Research

Study Reveals High Turnover in Scientific Research Careers: What This Means for Future Scientists

Why It's So Difficult to Lose Weight: The Biological Explanation Behind Obesity

Nikolay Karpenko Biography, Photo, Career, Accomplishments

Recommended Stories

NASA Shuts Down Voyager 2 Science Instrument After 47 Years to Conserve Energy

OpenAI’s Whisper Faces Scrutiny Over Accuracy, Experts Find 'Hallucinated' Text in Transcripts

Martian Ice May Support Microbial Life Beneath Its Surface, New Study Suggests

NASA Astronaut Hospitalized After Returning from Extended Space Mission